High-Dose-Rate Brachytherapy Monotherapy Is Safe and Highly Effective for Intermediate Risk Prostate Cancer Patients

Journal article

Peer reviewed

Shyamal Patel, Omar Ragab, Mingle Zhang, Kristine K. Nguyen, Darlene Veruttipong, Sang-June Park, D Jeffrey Demanes and Mitchell Kamrava

Brachytherapy, Vol.15, pp.S182-S182

05/2016

Files and links (1)

url

https://doi.org/10.1016/j.brachy.2016.04.333View

Published (Version of record) Open

1 Record Views

Title: High-Dose-Rate Brachytherapy Monotherapy Is Safe and Highly Effective for Intermediate Risk Prostate Cancer Patients
Creators: Shyamal Patel - University of California, Los Angeles
Omar Ragab - University of California, Los Angeles
Mingle Zhang - University of California, Los Angeles
Kristine K. Nguyen - University of California, Los Angeles
Darlene Veruttipong - University of California, Los Angeles
Sang-June Park
D Jeffrey Demanes - University of California, Los Angeles
Mitchell Kamrava - University of California, Los Angeles
Publication Details: Brachytherapy, Vol.15, pp.S182-S182
Identifiers: 991006262543702656
Academic Unit: Radiology
Language: English
Resource Type: Journal article